Posted by Max Byerly on Feb 3rd, 2026
Zenas BioPharma, Inc. (NASDAQ:ZBIO – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 6,086,840 shares, an increase...
More of this article »